Genotoxicity in risk assessment: is it time to use a threshold approach?

Abstract Substances that act via a genotoxic mechanism are considered to follow a low dose linear relationship with the absence of a threshold. The discussion on the existence of a threshold for genotoxic (mutagenic and clastogenic) compounds appears sometimes more an academic exercise than of practical use in public health. However, pragmatically, determination of the PoD, i.e. the dose/concentration from which we derive acceptable exposure levels, should be the goal. This will include appropriate dose response data analysis, with statistically defensible methods and use of mechanistic data, and application of adequate uncertainty factors. The best and full use of the quantitative information can be used to analyse dose–response data, and dismiss the binary classification scheme for use in risk assessment and management. Certainly, in areas such as the relationship between the genotoxic and the carcinogenic effect, the appropriate BenchMark Response (BMR) to be used, the relation between effects in target tissues vs those observed in surrogate tissues, and the uncertainty of our measurements there is a need of more solid data. While the simple binary classification scheme can be of some help for screening and prioritization of substances that need further scrutiny, it is not an adequate tool to be used for risk management decisions. The final step of the assessment for guiding management decisions should be quantitative to the extent possible. Accepting the threshold approach on which to base the risk management decisions has significant beneficial economic and societal impact and implications.

[1]  H M Bolt,et al.  Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. , 2003, Annual review of pharmacology and toxicology.

[2]  Lutz Müller,et al.  In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. , 2009, Mutation research.

[3]  T. E. Johnson,et al.  Human liver S‐9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/β‐naphthoflavone or Aroclor 1254 induced ratS‐9 , 1996, Environmental and molecular mutagenesis.

[4]  G. Johnson,et al.  N-methylpurine DNA glycosylase plays a pivotal role in the threshold response of ethyl methanesulfonate-induced chromosome damage. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  S. Dertinger,et al.  Practical threshold for micronucleated reticulocyte induction observed for low doses of mitomycin C, Ara-C and colchicine. , 2006, Mutagenesis.

[6]  J. T. Macgregor,et al.  IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

[7]  J. T. Macgregor,et al.  IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

[8]  M. LeBaron,et al.  Dose-Response for Multiple Biomarkers of Exposure and Genotoxic Effect Following Repeated Treatment of Rats with the Alkylating Agents, MMS and MNU. , 2016, Mutagenesis.

[9]  Andreas Zeller,et al.  A proposal for a novel rationale for critical effect size in dose-response analysis based on a multi-endpoint in vivo study with methyl methanesulfonate. , 2016, Mutagenesis.

[10]  José Cortiñas Abrahantes,et al.  Update: use of the benchmark dose approach in risk assessment , 2017, EFSA journal. European Food Safety Authority.

[11]  Leslie Recio,et al.  Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  R. W. Lutz,et al.  Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data. , 2009, Mutation research.

[13]  M. Kirsch‐Volders,et al.  Potential thresholds for genotoxic effects by micronucleus scoring. , 2011, Mutagenesis.

[14]  T. Singer,et al.  EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view. , 2009, Toxicology letters.

[15]  S Albertini,et al.  Thresholds in genotoxicity responses. , 2000, Mutation research.

[16]  C. Berry.  The dangers of hazards. , 2016, Toxicology research.

[17]  S. Fukushima,et al.  Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens. , 2016, Mutagenesis.

[18]  P. White,et al.  MutAIT: an online genetic toxicology data portal and analysis tools. , 2016, Mutagenesis.

[19]  P. White,et al.  Empirical analysis of BMD metrics in genetic toxicology part II: in vivo potency comparisons to promote reductions in the use of experimental animals for genetic toxicity assessment. , 2016, Mutagenesis.

[20]  Jan G Hengstler,et al.  Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. , 2004, Toxicology letters.

[21]  Angelo Moretto,et al.  Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society. , 2016, Regulatory toxicology and pharmacology : RTP.

[22]  P. White,et al.  Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene , 2017, Archives of Toxicology.

[23]  Lynn H Pottenger,et al.  Genotoxicity testing: Moving beyond qualitative “screen and bin” approach towards characterization of dose‐response and thresholds , 2010, Environmental and molecular mutagenesis.

[24]  Melvin E Andersen,et al.  Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro. , 2016, Mutagenesis.

[25]  Peter Kasper,et al.  Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative. , 2007, Mutation research.

[26]  E. Zeiger,et al.  Quantitative approaches for assessing dose–response relationships in genetic toxicology studies , 2013, Environmental and molecular mutagenesis.

[27]  G. Jenkins,et al.  Do dose response thresholds exist for genotoxic alkylating agents? , 2005, Mutagenesis.

[28]  Anthony Lynch,et al.  Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. , 2003, Mutagenesis.